Histone deacetylase 4 is required for TGF beta 1-induced myofibroblastic differentiation

[en] Transforming Growth Factor beta 1 (TGF beta 1) is a crucial cytokine triggering myofibroblastic (MF) differentiation, a process involved in tissue healing as well as in pathologic conditions such as fibrosis and cancer. Together with cell shape modifications, TGF beta 1-mediated differentiation of fibroblasts into myofibroblasts is characteristically associated with the neo-expression of smooth muscle alpha-actin (alpha-SMA), a cytoskeletal protein that enhances their contractile activity. Several cellular differentiation programs have been linked to epigenetic regulation of gene expression, including gene methylation and historic acetylation. Herein, we sought to investigate the role of histone deacetylases (HDAC) in TGF beta 1-induced MY differentiation. We found that TSA, a global inhibitor of class I and class II HDACs, prevented alpha-SMA transcript and protein expression and morphological changes mediated by TGF beta 1 in cultured human skin fibroblasts. In order to identify the HDAC(s) participating in MF differentiation, the impact of specific HDAC silencing (HDAC1 through HDAC8) using RNA interference was investigated in fibroblasts exposed to TGF beta 1. Among the eight HDACs tested, silencing of HDAC4, HDAC6, and HDAC8 expression impaired TGF beta 1-induced alpha-SMA expression. HDAC4 silencing most efficiently abrogated alpha-SMA expression and also prevented TGF beta 1-mediated morphological changes. Forced down-regulation of HDAC4 stimulated the expression of 5'-TG-3'-Interacting Factor (TGIF) and TGIF2 homeoproteins, two known endogenous repressors of the TGF beta signaling pathway, but not of the inhibitory Smad7. Collectively, these data suggest that HDAC4 is an essential epigenetic regulator of MF differentiation and unveil HDAC4 as a potential target for treating MF-related disorders. (C) 2007 Published by Elsevier B.V.

Disciplines :

Biochemistry, biophysics & molecular biology

Author, co-author :

Glenisson, Wendy

Castronovo, Vincenzo ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biologie générale et cellulaire

Waltregny, David ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Labo de recherche sur les métastases

Language :

English

Title :

Histone deacetylase 4 is required for TGF beta 1-induced myofibroblastic differentiation

Publication date :

October 2007

Journal title :

BBA Molecular Cell Research

ISSN :

0167-4889

Publisher :

Elsevier Science Bv, Amsterdam, Netherlands

Volume :

1773

Issue :

Pages :

1572-1582

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 25 January 2009

Statistics

Number of views

263 (3 by ULiège)

Number of downloads

1 (0 by ULiège)

More statistics

Scopus citations^®

140

Scopus citations^®
without self-citations

137

OpenCitations

127

Bibliography

Verrecchia F., and Mauviel A. Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. J. Invest. Dermatol. 118 (2002) 211-215
Roberts A.B., Sporn M.B., Assoian R.K., Smith J.M., Roche N.S., Wakefield L.M., Heine U.I., Liotta L.A., Falanga V., and Kehrl J.H. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. U. S. A. 83 (1986) 4167-4171
Desmouliere A., Geinoz A., Gabbiani F., and Gabbiani G. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J. Cell Biol. 122 (1993) 103-111
Ronnov-Jessen L., and Petersen O.W. Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Lab. Invest. 68 (1993) 696-707
Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J. Pathol. 200 (2003) 500-503
Powell D.W., Mifflin R.C., Valentich J.D., Crowe S.E., Saada J.I., and West A.B. Myofibroblasts. I. Paracrine cells important in health and disease. Am. J. Physiol. 277 (1999) C1-C9
Gabbiani G., Ryan G.B., and Majne G. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 27 (1971) 549-550
Skalli O., Ropraz P., Trzeciak A., Benzonana G., Gillessen D., and Gabbiani G. A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. J. Cell Biol. 103 (1986) 2787-2796
Grinnell F. Fibroblasts, myofibroblasts, and wound contraction. J. Cell Biol. 124 (1994) 401-404
Ronnov-Jessen L., Petersen O.W., and Bissell M.J. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol. Rev. 76 (1996) 69-125
Serini G., and Gabbiani G. Mechanisms of myofibroblast activity and phenotypic modulation. Exp. Cell Res. 250 (1999) 273-283
Hinz B., Celetta G., Tomasek J.J., Gabbiani G., and Chaponnier C. Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol. Biol. Cell 12 (2001) 2730-2741
Hinz B., Gabbiani G., and Chaponnier C. The NH2-terminal peptide of alpha-smooth muscle actin inhibits force generation by the myofibroblast in vitro and in vivo. J. Cell Biol. 157 (2002) 657-663
Heldin C.H., Miyazono K., and ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390 (1997) 465-471
Derynck R., Zhang Y., and Feng X.H. Smads: transcriptional activators of TGF-beta responses. Cell 95 (1998) 737-740
Wotton D., and Massague J. Smad transcriptional corepressors in TGF beta family signaling. Curr. Top Microbiol. Immunol. 254 (2001) 145-164
Massague J., and Wotton D. Transcriptional control by the TGF-beta/Smad signaling system. EMBO J. 19 (2000) 1745-1754
Izutsu K., Kurokawa M., Imai Y., Maki K., Mitani K., and Hirai H. The corepressor CtBP interacts with Evi-1 to repress transforming growth factor beta signaling. Blood 97 (2001) 2815-2822
Long J., Matsuura I., He D., Wang G., Shuai K., and Liu F. Repression of Smad transcriptional activity by PIASy, an inhibitor of activated STAT. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 9791-9796
Kume S., Haneda M., Kanasaki K., Sugimoto T., Araki S., Isshiki K., Isono M., Uzu T., Guarente L., Kashiwagi A., and Koya D. SIRT1 inhibits transforming growth factor beta-induced apoptosis in glomerular mesangial cells via Smad7 deacetylation. J. Biol. Chem. 282 (2007) 151-158
Verdin E. Histone Deacetylases: Transcriptional Regulation and other Cellular Functions (2006), Human Press, Totowa, New Jersey
Kim M.S., Kwon H.J., Lee Y.M., Baek J.H., Jang J.E., Lee S.W., Moon E.J., Kim H.S., Lee S.K., Chung H.Y., Kim C.W., and Kim K.W. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat. Med. 7 (2001) 437-443
Deroanne C.F., Bonjean K., Servotte S., Devy L., Colige A., Clausse N., Blacher S., Verdin E., Foidart J.M., Nusgens B.V., and Castronovo V. Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling. Oncogene 21 (2002) 427-436
Rombouts K., Niki T., Greenwel P., Vandermonde A., Wielant A., Hellemans K., De Bleser P., Yoshida M., Schuppan D., Rojkind M., and Geerts A. Trichostatin A, a histone deacetylase inhibitor, suppresses collagen synthesis and prevents TGF-beta(1)-induced fibrogenesis in skin fibroblasts. Exp. Cell Res. 278 (2002) 84-197
Rishikof D.C., Ricupero D.A., Liu H., and Goldstein R.H. Phenylbutyrate decreases type I collagen production in human lung fibroblasts. J. Cell. Biochem. 91 (2004) 740-748
Ghosh A.K., Mori Y., Dowling E., and Varga J. Trichostatin A blocks TGF-beta-induced collagen gene expression in skin fibroblasts: involvement of Sp1. Biochem. Biophys. Res. Commun. 354 (2007) 420-426
Waltregny D., Glenisson W., Tran S.L., North B.J., Verdin E., Colige A., and Castronovo V. Histone deacetylase HDAC8 associates with smooth muscle alpha-actin and is essential for smooth muscle cell contractility. FASEB J. 19 (2005) 966-968
Hubbert C., Guardiola A., Shao R., Kawaguchi Y., Ito A., Nixon A., Yoshida M., Wang X.F., and Yao T.P. HDAC6 is a microtubule-associated deacetylase. Nature 417 (2002) 455-458
Dequiedt F., Kasler H., Fischle W., Kiermer V., Weinstein M., Herndier B.G., and Verdin E. HDAC7, a thymus-specific class II histone deacetylase, regulates Nur77 transcription and TCR-mediated apoptosis. Immunity 18 (2003) 687-698
North B.J., Marshall B.L., Borra M.T., Denu J.M., and Verdin E. The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol. Cell 11 (2003) 437-444
Waltregny D., de Leval L., Glenisson W., Ly Tran S., North B.J., Bellahcene A., Weidle U., Verdin E., and Castronovo V. Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues. Am. J. Pathol. 165 (2004) 553-564
Hu B., Wu Z., and Phan S.H. Smad3 mediates transforming growth factor-beta-induced alpha-smooth muscle actin expression. Am. J. Respir. Cell Mol. Biol. 29 (2003) 397-404
Valcourt U., Kowanetz M., Niimi H., Heldin C.H., and Moustakas A. TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol. Biol. Cell 16 (2005) 1987-2002
Chen S.J., Yuan W., Mori Y., Levenson A., Trojanowska M., and Varga J. Stimulation of type I collagen transcription in human skin fibroblasts by TGF-beta: involvement of Smad 3. J. Invest. Dermatol. 112 (1999) 49-57
Kato S., Ueda S., Tamaki K., Fujii M., Miyazono K., ten Dijke P., Morimatsu M., and Okuda S. Ectopic expression of Smad7 inhibits transforming growth factor-beta responses in vascular smooth muscle cells. Life Sci. 69 (2001) 2641-2652
Lindert S., Wickert L., Sawitza I., Wiercinska E., Gressner A.M., Dooley S., and Breitkopf K. Transdifferentiation-dependent expression of alpha-SMA in hepatic stellate cells does not involve TGF-beta pathways leading to coinduction of collagen type I and thrombospondin-2. Matrix Biol. 24 (2005) 198-207
Camoretti-Mercado B., Fernandes D.J., Dewundara S., Churchill J., Ma L., Kogut P.C., McConville J.F., Parmacek M.S., and Solway J. Inhibition of transforming growth factor beta-enhanced serum response factor-dependent transcription by SMAD7. J. Biol. Chem. 281 (2006) 20383-20392
Tomasek J.J., Gabbiani G., Hinz B., Chaponnier C., and Brown R.A. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat. Rev., Mol. Cell Biol. 3 (2002) 349-363
Yoshikawa M., Hishikawa K., Marumo T., and Fujita T. Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells. J. Am. Soc. Nephrol. 18 (2007) 58-65
Pazmany T., and Tomasi T.B. The major histocompatibility complex class II transactivator is differentially regulated by interferon-gamma and transforming growth factor-beta in microglial cells. J. Neuroimmunol. 172 (2006) 18-26
Young D.A., Billingham O., Sampieri C.L., Edwards D.R., and Clark I.M. Differential effects of histone deacetylase inhibitors on phorbol ester- and TGF-beta1 induced murine tissue inhibitor of metalloproteinases-1 gene expression. FEBS J. 272 (2005) 1912-1926
Kang J.S., Alliston T., Delston R., and Derynck R. Repression of Runx2 function by TGF-beta through recruitment of class II histone deacetylases by Smad3. EMBO J. 24 (2005) 2543-2555
Vega R.B., Matsuda K., Oh J., Barbosa A.C., Yang X., Meadows E., McAnally J., Pomajzl C., Shelton J.M., Richardson J.A., Karsenty G., and Olson E.N. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 119 (2004) 555-566
McKinsey T.A., Zhang C.L., Lu J., and Olson E.N. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408 (2000) 106-111
Miska E.A., Langley E., Wolf D., Karlsson C., Pines J., and Kouzarides T. Differential localization of HDAC4 orchestrates muscle differentiation. Nucleic Acids Res. 29 (2001) 3439-3447
Karamboulas C., Swedani A., Ward C., Al-Madhoun A.S., Wilton S., Boisvenue S., Ridgeway A.G., and Skerjanc I.S. HDAC activity regulates entry of mesoderm cells into the cardiac muscle lineage. J. Cell. Sci. 119 (2006) 4305-4314
Ellis J.J., Valencia T.G., Zeng H., Roberts L.D., Deaton R.A., and Grant S.R. CaM kinase IIdeltaC phosphorylation of 14-3-3beta in vascular smooth muscle cells: activation of class II HDAC repression. Mol. Cell. Biochem. 242 (2003) 153-161
Cao D., Wang Z., Zhang C.L., Oh J., Xing W., Li S., Richardson J.A., Wang D.Z., and Olson E.N. Modulation of smooth muscle gene expression by association of histone acetyltransferases and deacetylases with myocardin. Mol. Cell. Biol. 25 (2005) 364-376
Melhuish T.A., Gallo C.M., and Wotton D. TGIF2 interacts with histone deacetylase 1 and represses transcription. J. Biol. Chem. 276 (2001) 32109-32114
Sharma M., and Sun Z. 5′TG3′ interacting factor interacts with Sin3A and represses AR-mediated transcription. Mol. Endocrinol. 15 (2001) 1918-1928
Melhuish T.A., and Wotton D. The Tgif2 gene contains a retained intron within the coding sequence. BMC Mol. Biol. 7 (2006) 2
Seo S.R., Lallemand F., Ferrand N., Pessah M., L'Hoste S., Camonis J., and Atfi A. The novel E3 ubiquitin ligase Tiul1 associates with TGIF to target Smad2 for degradation. EMBO J. 23 (2004) 3780-3792
Kopp J., Preis E., Said H., Hafemann B., Wickert L., Gressner A.M., Pallua N., and Dooley S. Abrogation of transforming growth factor-beta signaling by SMAD7 inhibits collagen gel contraction of human dermal fibroblasts. J. Biol. Chem. 280 (2005) 21570-21576
Li J.H., Zhu H.J., Huang X.R., Lai K.N., Johnson R.J., and Lan H.Y. Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation. J. Am. Soc. Nephrol. 13 (2002) 1464-1472
Dai C., and Liu Y. Hepatocyte growth factor antagonizes the profibrotic action of TGF-beta1 in mesangial cells by stabilizing Smad transcriptional corepressor TGIF. J. Am. Soc. Nephrol. 15 (2004) 1402-1412
Chen F., Ogawa K., Nagarajan R.P., Zhang M., Kuang C., and Chen Y. Regulation of TG-interacting factor by transforming growth factor-beta. Biochem. J. 371 (2003) 257-263
Itoh S., Landstrom M., Hermansson A., Itoh F., Heldin C.H., Heldin N.E., and ten Dijke P. Transforming growth factor beta1 induces nuclear export of inhibitory Smad7. J. Biol. Chem. 273 (1998) 29195-29201